FDAnews
www.fdanews.com/articles/81324-stem-cell-therapeutics-corp-and-medicon-a-s-sign-contract-to-perform-phase-i-clinical-study

STEM CELL THERAPEUTICS CORP. AND MEDICON A/S SIGN CONTRACT TO PERFORM PHASE I CLINICAL STUDY

September 30, 2005

Stem Cell Therapeutics Corp. ("SCT") announced today that they have signed a contract with Medicon A/S ("Medicon") of Birkerod, Denmark to perform a Phase I clinical trial. The contract encompasses submission of SCT's Phase I clinical trial protocol, screening, conduct and reporting of trial results. This agreement follows the successful clinical trial feasibility assessment and positive regulatory response that Medicon and SCT have achieved to date.

Canada NewsWire (http://www.newswire.ca/en/releases/archive/September2005/29/c5556.html%20)